Navigation Links
Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects
Date:2/17/2009

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced that it will fund two new especially innovative and high-risk research projects. The Joint Committee of Germany's largest research funding organisation, located in Bonn, has approved funding for two new Reinhart Koselleck Projects. Professor Margit Zacharias, a nanotechnologist from Freiburg, and Professor Reinhard Drner, an atomic physicist from Frankfurt, have each been awarded 1.25 million euros, which they will be able to use flexibly for their projects over the next five years.

"With our Reinhart Koselleck project funding we aim to promote outstanding researchers who have adventurous ideas and are willing to undertake higher-risk research," commented Professor Matthias Kleiner, President of the DFG, during the DFG's Joint Committee session. It was the second time that the Joint Committee has approved funding under this programme, following the first Reinhart Koselleck awards in December 2008, when six researchers were granted Reinhart Koselleck Project funding. The Reinhart Koselleck programme, named after the late renowned historian from Bielefeld, who died in 2006, fills a gap in the DFG's funding programmes and in the German research funding landscape as a whole. "In the past even noted researchers who had wanted to do promising, higher-risk research had almost no way of applying for funding," said the President of the DFG. Since it is usually more difficult to plan especially innovative and high-risk research than is the case for normal research work, only a five-page project outline is required to apply for Reinhart Koselleck Project funding. In addition to the ambitious project ideas, the applicants' proven track records play a crucial role in the review process. "The Koselleck Projects," said Kleiner, "are an enormous vote of confidence that needs to be earned." The DFG's Joint Committee found that these very demanding requirements were met by the project
'/>"/>

Contact: Marco Finetti
marco.finetti@dfg.de
49-228-885-2230
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Genmab Announces Encouraging Preclinical Data for ofatumumab
4. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
5. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
6. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
7. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
8. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
9. Nycomeds Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies
10. Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia
11. U-M research: New plastic is strong as steel, transparent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , October 20, 2014 , ... (GI) disorders and the delivery of care has revealed ... and worrying inequalities in the provision of healthcare services ... was commissioned by United European Gastroenterology (UEG), have been ... and public awareness of the burden of GI disorders ...
(Date:10/20/2014)... October 20, 2014 Earle ... LLC, announced today that Ellen Teplitzky, an experienced ... for the pharmaceutical industry, has joined the firm ... its legal services practice. NDA Partners provides ... witness and testimony, to top law firms and ...
(Date:10/19/2014)... Mass. , Oct. 19, 2014 NextCODE Health, ... the whole genome in real time, today announced the launch ... NextCODE Exchange , at the American Society of Human ... . To learn more, sign up and apply for free ... its unique features and benefits can be viewed here ...
(Date:10/19/2014)... October 19, 2014 The report "Chocolate, ... Share, Trade, Prices, Geography Trend and Forecast (2011 - ... category, and geography and studies the major market drivers, ... America, Europe, and Asia. , The global chocolate market ... $98.3 billion in 2016 at an estimated CAGR of ...
Breaking Biology Technology:Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... and Mayo Foundation,for Medical Education and Research announced ... systems biology (CSB(TM)) profiling to,breast cancer patient stratification. ... profile test to improve diagnosis and treatment for ... an exciting research and development,program with Mayo, a ...
... E. Nedwin, Ph.D., MBA to Join Genencor,s Senior ... Genencor, a division of Danisco,A/S, today announced that ... as,Executive Vice President - Technical Enzymes, effective Oct. ... Management Team, Dr. Nedwin will head the,division,s activities ...
... MUNICH, Germany, October 1 - New Product ... - Approval Requested in 28 European Countries DAIICHI ... for,approval of a new antihypertensive medication. It is a ... (ARB),Olmesartan and the calcium antagonist Amlodipin. When approved, ...
Cached Biology Technology:Genencor Appoints New Executive Vice President - Technical Enzymes 2DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin 2
(Date:10/17/2014)... University of Copenhagen have shown for the first time ... Cystic fibrosis patients, giving them the opportunity to get ... infections. , The study also discovered the bacterial growth ... was halted or slowed down by the immune cells. ... oxygen and helped "suffocate" the bacteria, forcing the bacteria ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... – Post-menopausal women experienced improvements in vaginal atrophy, ... genital bleeding, after 12 weeks of daily 10 ... germ-based nutritional supplement previously shown to help relieve ... pilot study reported in a poster at the ... , "These data documented improved vaginal epithelium, ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2New report synthesizes best available science on management of moist mixed-conifer forests 2S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2
... Feb. 29 /Xinhua-PRNewswire/ -- Futronic Technology Company,Limited, ... hardware products,today announced that the latest version ... and Windows 2008 Server., FinLogon is ... using proprietary fingerprint recognition technology. By a,finger ...
... of impact strata on Mars, Holden Crater; Eocene-Oligocene ... that liquid water is not responsible for recent ... Cretaceous early Albian greenhouse conditions and implications for ... Earth,s copper supply; discovery of large nitrate pools ...
... biochemistry, has received the National Science Foundation,s prestigious ... competitive funding award, designed to support the integrated ... their careers, is bestowed on those scientists and ... leaders of the 21st century. Fewer than 20 ...
Cached Biology News:Futronic Announces Microsoft Vista and Windows 2008 Server Support for Its Fingerprint Logon Software 2March GEOLOGY and GSA TODAY media highlights 2March GEOLOGY and GSA TODAY media highlights 3March GEOLOGY and GSA TODAY media highlights 4March GEOLOGY and GSA TODAY media highlights 5March GEOLOGY and GSA TODAY media highlights 6March GEOLOGY and GSA TODAY media highlights 7March GEOLOGY and GSA TODAY media highlights 8March GEOLOGY and GSA TODAY media highlights 9March GEOLOGY and GSA TODAY media highlights 10March GEOLOGY and GSA TODAY media highlights 11March GEOLOGY and GSA TODAY media highlights 12March GEOLOGY and GSA TODAY media highlights 13March GEOLOGY and GSA TODAY media highlights 14March GEOLOGY and GSA TODAY media highlights 15UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals 2UD's Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals 3
APO-BrdU™ TUNEL Assay Kit *with Alexa Fluor® 488 anti-BrdU* *60 assays*...
...
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
RayBio Human Cytokine Antibody Array 1.1 (4 array membranes) with Accessory, detects 20 cytokines (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: